<SEC-DOCUMENT>0001193125-18-281666.txt : 20180925
<SEC-HEADER>0001193125-18-281666.hdr.sgml : 20180925
<ACCEPTANCE-DATETIME>20180925060605
ACCESSION NUMBER:		0001193125-18-281666
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180925
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180925
DATE AS OF CHANGE:		20180925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WESTLAKE CHEMICAL CORP
		CENTRAL INDEX KEY:			0001262823
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				760346924
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32260
		FILM NUMBER:		181084604

	BUSINESS ADDRESS:	
		STREET 1:		2801 POST OAK BLVD
		STREET 2:		SUITE 600
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		713-960-9111

	MAIL ADDRESS:	
		STREET 1:		2801 POST OAK BLVD
		STREET 2:		SUITE 600
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d631324d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (date of earliest event reported): September&nbsp;25, 2018 </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Westlake Chemical Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-32260</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">76-0346924</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Commission File Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2801 Post Oak Boulevard, Suite 600</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Houston, Texas</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>77056</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip Code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code:
<FONT STYLE="white-space:nowrap">(713)&nbsp;960-9111</FONT> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17
CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT
STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 <FONT STYLE="white-space:nowrap">(&#167;240.12b-2</FONT> of this chapter). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging
growth company&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;7.01. Regulation FD Disclosure. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;25, 2018, Westlake Chemical Corporation issued a press release announcing that it has made an exclusive, binding offer to
acquire NAKAN&#153;, a global compounding solutions business, through the acquisition of all of the outstanding shares of Ivy Group Holding SAS. A copy of the press release is furnished with this Current Report as Exhibit 99.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information furnished pursuant to this Current Report, including Exhibit 99.1, shall not be deemed to be &#147;filed&#148; for the
purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liability of such section, nor shall such information be deemed incorporated by reference into any filing by
Westlake Chemical Corporation under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;9.01. Financial Statements and Exhibits. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
exhibit is furnished herewith: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d631324dex991.htm">Press release issued on September&nbsp;25, 2018. </A></TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WESTLAKE CHEMICAL</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATION</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:&nbsp;&nbsp;September&nbsp;25, 2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000">/S/ L. BENJAMIN EDERINGTON</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>L. Benjamin Ederington</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Senior Vice President, General Counsel,</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Chief Administrative Officer and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Corporate Secretary</B></P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d631324dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g631324g0924134209714.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WESTLAKE CHEMICAL ANNOUNCES OFFER TO ACQUIRE NAKAN PVC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPOUNDING SOLUTIONS BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOUSTON, September</B><B></B><B>&nbsp;25, 2018</B> &#151; Westlake Chemical Corporation (NYSE: WLK) announced today that it has issued an exclusive,
binding offer to acquire NAKAN, a global compounding solutions business, from Los Angeles-based private equity firm, OpenGate Capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NAKAN,
headquartered in Reims, France, has eight production facilities, located in China, France, Germany, Italy, Japan, Mexico, Spain and Vietnam, as well as a world-class research facility in France and application laboratory in the United States.
NAKAN&#146;s products are used in a wide-variety of applications, including in the automotive, building and construction, and medical industries. NAKAN generated approximately $300&nbsp;million of revenue in the most recent twelve-month period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the offer, which is subject to exclusivity protection, Westlake will pay approximately $265&nbsp;million in cash, subject to adjustment.
The binding offer was made in order to permit NAKAN to proceed with its consultation obligations with French works councils prior to entering into a negotiated, mutually binding purchase agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The combination of NAKAN with Westlake&#146;s existing compounding business will present an excellent strategic fit. It will allow us to expand our
compounding business globally and add important specialty products and technology to our existing portfolio,&#148; said Albert Chao, Westlake&#146;s President and Chief Executive Officer. &#147;NAKAN is an impressive business with an outstanding
reputation for meeting customer needs with superior technology, product quality, and operating excellence. We look forward to working with their talented team once they join the Westlake family of companies.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction is expected to close by early 2019, subject to receipt of regulatory approvals, completion of required employee consultation procedures and
other customary closing conditions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Westlake </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Westlake Chemical Corporation is an international manufacturer and supplier of petrochemicals, polymers and building products with headquarters in Houston. The
company&#146;s range of products includes: ethylene, polyethylene, styrene, propylene, chlor-alkali and derivative products, PVC suspension and specialty resins, PVC compounds, and PVC building products including siding, pipe, fittings and specialty
components, windows, fence, deck and film. For more information, visit the company&#146;s website at <U>www.westlake.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement
Regarding Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for the historical information contained herein, the matters discussed in this press release are
forward-looking statements that involve certain risks and uncertainties. These risks and uncertainties relate to, among other things, the risks and uncertainties inherent in the petrochemicals, polymers and building products industries discussed in
our filings with the Securities and Exchange Commission, as well as the risks and uncertainties inherent in the binding offer and transaction involving NAKAN. Forward-looking statements, like all statements in this press release, speak only as of
the date of this press release (unless another date is indicated). We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Media Inquiries: </I>Benjamin Ederington, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-960-9111</FONT></FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investor Inquiries: </I>Steve Bender, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">713-960-9111</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g631324g0924134209714.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g631324g0924134209714.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  [ +D# 2(  A$! Q$!_\0
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M;7TL=[_9MA_SY6__ 'Z%']FV'_/E;_\ ?H5F^%_%-EXLTV6_T^*=(HY3$1,
M&+  ]B?45HV>H)>R7$:12(T#['W@8S[8J&JB;3Z%KV;M;J+_ &;8_P#/E;_]
M^A1_9MC_ ,^5O_WZ6JNN:U_86GRWTMC=7-O$NZ1K<*2@[G!(./I2>'-?MO$V
MC1ZI9PSQ02,RH)U"DX.,\$\4>_R\W0+0ORVU+&G1I$EPD:JJ+.V%48 Z5=JK
M9=;K_KX;^E<)\9]-GD\!W>K6%U=VU_IX5T>WN'CRA8!@0I /!SSZ5$MRH;'H
MM%>5>"_$46D? ]?$*//<W[QLI$TSRM-<[S&@&XGJ=O JI\$O$4FO>%=7\/ZW
M-*]W8ROYIDD8.8I,YYSD$-NZ'C(I%'L%%><?#&&VL/"MWXGO[^X6&]GFDB>]
MO'9(+4.1&OSM@<#.>IS74Z-XU\-^(+U[+2M8MKFZ1=QA!*L1Z@$#(^E &]17
M/:OXZ\,Z%>O9ZCJT45S&NZ2-$:0QCU;:#M'UQ7/?$SQY-X=^'\.N^'[FTEDN
MY42"5QO#(P)W*.YX% 'H5(K*Z[E8,IZ$'(KR[QY=67B#X,W6H1ZBEU>65K$[
M36MSC;*=F[<$..<G@^M;WPODBMOA1H,LTB1Q):%W=VPJC<222>E ':4C,J#+
M,%!..3CFN<TKQ_X3US4_[.TW7;2XO#G;$K$%L==N1AOPKS;XGV$5O\7O \L3
M2@WMXC3*9F*,5D0 A2<#@]@* /;:*R]4\2:-HMW;VNHZE;VUQ<_ZF)V^9^<<
M#K3M9\0:1X>MUGU;4(;1'.U/,;YG/HJCD_@* -*BLW1?$&D^([,W>CZA!>P!
MMK-$V=I]".H/UK2H JZ;_P @JT_ZXI_(5ROC&T\N]ANE'$J[6^H_^M_*NJTW
M_D%VG_7%/Y"J7B6T^U:)-@9>+]XOX=?TS730J<E9,Y:]/GH6\CE?#%W]EUJ-
M2<),/+/U[?K7EOQ1T?\ LCQW>%%VPW@%U'QQ\WWO_'@?SKNT=D=70X92&!]Q
M4?QBL%U+PSI7B"%06A;RY"/[KC^C#'XUZ<OW>(C+^;0\VB^>A*';4Q/A!XC&
MESZMI\K?++#]HA7UD7@@?4$?E7M6DVC6>G1I(<S/F24^KGDU\M>'M271_$>G
M:@XS'!<*T@]5SS^F:^L597570AE89!'<5R9A'EE==3MP3YEKT.7\>WTL/ATZ
M;:<W^K2"QMQZ;_O-] N36]I>G0:1I5KIULNV&VB6)/H!U_&N:LA_PD'Q"N[\
M_-9:&AM+?T:X<9D;\!A?Q-=A7%/2*C\SKCJW(JV76Z_Z^&_I4&OZ:NL^'=2T
MQ@"+JUDA_%E('ZU/9=;K_KX;^E6JB6Y4=CYP^"8O=?FM-!N(B--T.^?4Y2?X
MI2H6)/P;>_X5#X[2_P#A_P#%G4I]*C/E>(;.1(U!P-\P*G\1)AOQKWCPUX1T
MGPI_:']EQR*;^Y:YF+MD[CV''"CG ]Z->\(:3XDU'2;[48G:?2I_/MRC8^;(
M.&XY&5!Q[4BCR?XQQ2>'="\"Z+$8_P"S[>94E64GRG,80#?CMRQ/XUT]UX%\
M2:YX^T+Q5>W.C6G]FE018F1C-'DG&2!V)'T-=IXH\*Z3XPTAM,UBW,L.X.C*
MVUXV'\2GL>M8GASX;6?AVYMI?[<UN^CM#FVMKJ[)ABXQ]P  XSQG@4 >?30>
M.O!.L^)==\/VVGZ[H=]=RSW!8[G7:S!E(R&ROS @9'%4/'=]I>O_ +/VBZM9
MZ6EGY5REM$A.]H0I=657/.T[1^E>H2_#B!FU"*W\0ZW:Z?J$LDMS913IL8N2
M7"DJ64')R :T-3\!Z!JG@Z/PM):M#ID07REA;#1D'(8'UY.<]<F@#F_&NGV&
MG? W5!8V=O;)+8Q.X@B"!V.SDXZGWK.L-=T;0/V?-'NM=M&O+*2W2+[*O_+9
MBQ(7Z?+D_2NF'PQT;_A%5\.->ZJ;$G,W^E?--TP&)'W1@8 P.*67X8Z%/X.?
MPM//J$VF[U>$23AFMR,XV'' Y/!SUH \O\5K>R_$OX?:G=:7I^ERWEQ&4BLW
M+/LWH0)#@ G#8X]^:V?C$]RGQ*\!FR2)[L3L85F)",_F)M#$<@9QFNJ'P=\,
M[=-<3:H+K3N8;L79\W(((.2.V!@# 'I5_7/AMI/B'6;;5;^_U5KNU*FV9+D*
M(2,<J-O!R ?K0!QWPH\0P7GBK6;/Q+;F'QJ96\R2?J\0Z1QC^$*.PZCGFLZY
MU#5W_:3OH;<6+W,5F(K)-0=E15V(QV;03N.6_6O0M<^&NA>(-4L=5NI+Z+4K
M.-42\MY_+E;;T9B!RP]?>F^*_AGH?BVYM;VZEO+74[5 D=]:R[)2!TR<8)'K
MUYH H>!/ >K>&?%6O:W?W=B(]6.\VEF&V1ON+9^;'J?SKT*L'PWX5A\.+,_]
MI:EJ-S,%$EQJ%R96P,X '11R>@K>H JZ;_R"[3_KBG\A5EE#HRL,JPP1[56T
MW_D%VG_7%/Y"K55+XF3#X4>6WML;.^GMF_Y9N5'T[?I6M%;QZ[X$UC1IF (B
M8H3V_B4_@PJQXNL'&H1W,4;,)4PVU<\C_P"M69I4,_VZ.!EECAG81RG8>5SG
M'Z5[$I*K04KZ[_<>+&+HUW&VFWWG@.#T88/0BOH'PSXR"?"5-3<^;>64?V0)
MW>486,?CE:\M\?\ AJYTOQKJ,5K9S/;3/Y\1BB8J _)' ['(K5^%UE>3^)[?
M3KZ*YBL(Y#?"-X6"O,BX3)([9S^ IXGDJTE/MJ:T.>G5<>^A[1X6T8Z#X=M;
M*1M]S@RW,G=Y6.YS^9-;-%%>*VV[L]9*RLBK9=;K_KX;^E<;\4_'[^!=!A-E
M$LVJWSF*U1QE5QU<COC(X]2*[*RZW7_7PW]*\5_:(L[B&7PWKJ1E[>UE>.3T
M#$JR_GM/Y42W%'8[/2?A[?WNG17/BGQ-KESJDJAY5MKUH(H2>=JJF.GK3(/#
M.LV%MXIT^]UW6+K2EMHY=.GEN")D8*Y8"1<,<$+U[&NYTO4[76=+M=2LI5EM
M;F,21NIZ@_U'2FZS_P @/4/^O:3_ -!-(H\I^#/B:PTOX;R7WB#68H&N-2E"
MRWD_+D(G0L<FO7K:Y@O+:.YM9HYX)5W))&P96'J".M?/WPV\):'K'P6UV^U"
MPBN+M/M/E32#+0[8PPV?W>>>.O>I/#^IW^F_LOZC<VDTB3+,\2.I.8T:55;'
MI]YOSH ]I'B[PX=6_LH:YIYORVW[.+A=^[TQGK[58OM>TC3)EAOM3L[>9V5%
MCDF4.Q;@ +G/->)P>#M<\;?"GP_8:9I.BVD<:I/%J NSYA89#$@)D,3G/)Y'
MM4_QETF)-0\!"\BBDO9K@07EP@VM-CR@<MUQUQZ9H ]?M?%.@7NK2Z5:ZQ93
M7\6=]NDREQCKQ[=_2ETSQ1H.M7<UIIFL65Y<0Y\R*&8,PQQG [>]>-_$#POH
M=C\7_!=I9Z;!;6]XP2XB@7RUD ?'./4'!]15F]TBPT']I;P_#I%K%90SV9>2
M*!0BD[)0>!QR%'Y4 =AK&FQ7/Q6T?55\9QVPA7R/[(68;I7PV0%![YYR.WY=
MQ?ZC9:59O>:A=PVMM']Z69PBC\37CWBFSM;;]I+PF\%O%$TUN9)2B ;W_>_,
M<=3P.:FO[F/7OVBTT36E6?3K&SWV=I,,QM*4#%MIX)P6_P"^1Z4 >IZ5K^CZ
MY;27.E:G:WD,1Q(\,H8(>O/I5;3_ !?X<U746T_3]<L+F[7/[F*=68XZX'?\
M*YOQ'IOA/P/X8\17U_ \>F:I*AGM+50FYMH78@&,9P2?J:\S\5PM_P )UX U
M:W\.VN@"\NX_*6"13)(@>/!=54*IPW3)ZD'I0!O_ !82>T^)'@PP7]ZL=_>I
MYT'VE_*.V2,#"9P.IKVVO%_C%_R4;X>?]?O_ +5BKVB@"GIO_(+M/^N*?R%6
MJX2#7-1B@CC2YPJH !L7@ ?2G_V_JG_/U_XXO^%=,L/*[...*ARK0[BBN'_M
M_5/^?K_QQ?\ "C^W]4_Y^O\ QQ?\*7U:17UN'9G<45P_]OZI_P _7_CB_P"%
M']OZI_S]?^.+_A1]6D'UN'9G<45P_P#;^J?\_7_CB_X4?V_JG_/U_P".+_A1
M]6D'UN'9G7676Z_Z^&_I3=5TJPUO3)].U*V2YM)UVR1N.#_@?<56\/327&FM
M-*VZ1YF+'&,UJUC-6DT;TW>*9YOIWPHF\/M(GAOQCK.F6;MN-MA)44^VX<?6
MM^'P8T6EWML_B+6)KJ]4)->32J[A!GY44KL0')Z#/O74T5)9Q?ASX;V7AG0=
M1T.SU749-.OHI$>*4QG8SKM+J0H.<>O'M4GA[X=:9X?\.7GA[[5=WVDW2L&M
MKK80N[[Q!50>>._&.*["B@#S;2/A&=#\RTTWQAKUMI,CEVLHI%7KU ?&1GU
M!K4\5?#>S\7:C9W=]J^I1"Q(:TAA:,+$WRY()4DDE0>2:[6B@#AM:^&<&O:[
M8:S>>(-6^W6 7[,\?E 1D8.[&S!)(R<_RJ?5?AU::IXNL?$YU;48-4LX5ACD
MB,>"!NR2"IZ[CGZUV5% '#ZK\-;?5_%L/B:77M5CU&WXMFC\K;"O.% *<CYC
MUSUI?&'PRTWQ9J-GJPOKO3M8M %2^M2 S =,CU![C%=O10!Q-]\.8M9\)W6A
MZYKNIZFUQ(L@NIF4-$R]-B@8 ZYZYS68WP:TJ6+2&EUS6I+W2SN@NGG#,,$%
M0 P("KM& !]<UZ310!Q'B/X:VWBC6;'5+_7-4$]@5:U$7E*(F&TEA\G))4'G
8^5:O_"/:O_T-^J?]^+?_ .-UT5% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
